<DOC>
<DOCNO>EP-0625571</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Microorganisms, their use and method of production of L-alpha-amino acids
</INVENTION-TITLE>
<CLASSIFICATIONS>C12N120	C12N121	C12N1509	C12P4100	C12P1300	C12N1509	C12P4100	C12N121	C12N986	C12R106	C12P1304	C12N120	C12N978	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C12N	C12N	C12N	C12P	C12P	C12N	C12P	C12N	C12N	C12R	C12P	C12N	C12N	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C12N1	C12N1	C12N15	C12P41	C12P13	C12N15	C12P41	C12N1	C12N9	C12R1	C12P13	C12N1	C12N9	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
N-5-Monosubstituted hydantoins can be converted by fermentation or enzymatically into the enantiomerically pure L- alpha -amino acid. The object comprises microorganisms which are simple to cultivate and make high L- alpha -amino acid yields possible from various substrates. The microorganisms DSM 7329 and 7330 are suitable for the production of L- alpha -amino acids from corresponding hydantoins or carbamoyl- alpha -amino acids. The reaction is preferably carried out with dormant microorganisms. Production of various L- alpha -amino acids.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
DEGUSSA
</APPLICANT-NAME>
<APPLICANT-NAME>
DEGUSSA-HUELS AKTIENGESELLSCHAFT
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BOMMARIUS ANDREAS DR
</INVENTOR-NAME>
<INVENTOR-NAME>
DRAUZ KARLHEINZ PROF DR
</INVENTOR-NAME>
<INVENTOR-NAME>
VOELKEL DIRK
</INVENTOR-NAME>
<INVENTOR-NAME>
WAGNER FRITZ PROF DR
</INVENTOR-NAME>
<INVENTOR-NAME>
BOMMARIUS, ANDREAS, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
DRAUZ, KARLHEINZ, PROF. DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
VOELKEL, DIRK
</INVENTOR-NAME>
<INVENTOR-NAME>
WAGNER, FRITZ, PROF. DR.
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Microorganism DSM 7329.
Microorganism DSM 7330.
Process for producing L-α-amino acids by enzymatic
conversion of a D-, L- and/or D,L-5-monosubstituted

hydantoin and/or a D-, L- and/or D,L-N-carbamoyl-α-amino
acid, characterised in that the conversion is

carried out by means of the microorganisms DSM 7329
and/or DSM 7330.
Process according to claim 3, characterised in that
the conversion is carried out with dormant

microorganisms.
Use of the microorganisms DSM 7329 and/or DSM 7330
for cultivating mutants or variants of these

microorganisms.
</CLAIMS>
</TEXT>
</DOC>
